Market Place
Sourcing Support
Enteris Presents Study of Ovarest showing Oral Delivery Comparable to Leuprolide
26 Oct 2022 //
PRNEWSWIRE
Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics
10 Oct 2022 //
PRNEWSWIRE
Enteris Publishes Paper Examining Factors to Consider While Evaluating Peptides
12 Sep 2022 //
PRNEWSWIRE
Enteris Bio Manufacturing Expertise Highlighted in Drug Development & Delivery
03 Aug 2022 //
PRNEWSWIRE
Enteris BioPharma Accepts Abstract for Oral Presentation at ASRM 2022
14 Jul 2022 //
PRNEWSWIRE
Enteris BioPharma Publishes Safe Handling and Manufacture of HPAPI
07 Jun 2022 //
PRNEWSWIRE
Enteris Employees Lend Ronald McDonald House a Helping Hand at Enteris Day 2022
26 May 2022 //
PRNEWSWIRE
Enteris BioPharma to Exhibit at CPhI North America 2022
04 May 2022 //
PRNEWSWIRE
Enteris Bio Announces Acceptance of Two Abstracts for Presentation at ENDO 2022
12 Apr 2022 //
PRNEWSWIRE
Enteris BioPharma as Game Changer in Drug Development & Delivery Special Feature
04 Apr 2022 //
PRNEWSWIRE
Enteris Publishes White Paper on Best Practices for Ensuring Content Uniformity
07 Mar 2022 //
PRNEWSWIRE
Enteris BioPharma, Receives $5M Milestone Payment from Cara Therapeutics
09 Dec 2021 //
PRNEWSWIRE
Enteris BioPharma to Participate in AAPS 2021 PHARMSCI 360 Conference
13 Oct 2021 //
PRNEWSWIRE
Enteris to Host Webinar on High Potency APIs in Oral Drug Development
15 Jun 2021 //
PRNEWSWIRE
Enteris BioPharma Receives $10M Milestone from Cara Therapeutics
14 Jun 2021 //
CONTRACTPHARMA
Enteris BioPharma Receives $10M Milestone from Cara Therapeutics
11 Jun 2021 //
CONTRACT PHARMA
Enteris BioPharma to Participate in BIO Digital 2021
07 Jun 2021 //
PRNEWSWIRE
Enteris BioPharma Announces Launch of CDMO Business Segment
03 May 2021 //
PRNEWSWIRE
Enteris BioPharma Highlights 2020 Achievements and 2021 Outlook
07 Jan 2021 //
PRNEWSWIRE
Enteris BioPharma to Participate in BIO International Digital Convention
02 Jun 2020 //
PRNEWSWIRE
Cara Therapeutics, Announces Top Line Data from Phase 2 Trial of Peptelligence
06 Dec 2019 //
PR NEWSWIRE
Licensing agreement formalizes drug delivery technology partnership
28 Aug 2019 //
IN-PHARMATECHNOLOGIST
SWK Holdings Corporation Acquires Enteris BioPharm
27 Aug 2019 //
BIOSPACE
Enteris, Cara Therapeutics Enter Peptelligence Pact
27 Aug 2019 //
CONTRACT PHARMA
Cara Therapeutics, Initiates Phase 2 Trial of Peptelligence
11 Jul 2019 //
PR NEWSWIRE
Enteris BioPharma Announces Positive Results Ph2a of Ovarest®
26 Jun 2018 //
PR NEWSWIRE
Enteris BioPharma Announces Completion of in Expanded Ph2a CTRL of Ovarest®
30 Apr 2018 //
PR NEWSWIRE
Enteris BioPharma Signs Oral Diabetes Pact with Sanofi
24 Jan 2017 //
FIERCE BIOTECH
Enteris BioPharma Launches Contract Biologics API Mfg
13 Feb 2015 //
DCAT CONNECT
